Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
2001 1
2005 1
2006 2
2008 1
2009 4
2010 7
2011 11
2012 11
2013 2
2014 4
2015 11
2016 7
2017 9
2018 14
2019 12
2020 4
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21540859

84 results

Results by year

Filters applied: . Clear all
Page 1
Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study.
Loulergue P, Alexandre J, Iurisci I, Grabar S, Medioni J, Ropert S, Dieras V, Le Chevalier F, Oudard S, Goldwasser F, Lebon P, Launay O. Loulergue P, et al. Br J Cancer. 2011 May 24;104(11):1670-4. doi: 10.1038/bjc.2011.142. Epub 2011 May 3. Br J Cancer. 2011. PMID: 21540859 Free PMC article. Clinical Trial.
Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
Narang V, Lu Y, Tan C, Camous XFN, Nyunt SZ, Carre C, Mok EWH, Wong G, Maurer-Stroh S, Abel B, Burdin N, Poidinger M, Tambyah PA, Bosco N, Visan L, Ng TP, Larbi A. Narang V, et al. Front Immunol. 2018 Oct 24;9:2465. doi: 10.3389/fimmu.2018.02465. eCollection 2018. Front Immunol. 2018. PMID: 30405641 Free PMC article. Clinical Trial.
A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoietic stem cell transplant.
Miller PDE, de Silva TI, Leonard H, Anthias C, Hoschler K, Goddard K, Peggs K, Madrigal A, Snowden JA. Miller PDE, et al. Vaccine. 2019 Jan 14;37(3):452-457. doi: 10.1016/j.vaccine.2018.11.061. Epub 2018 Dec 13. Vaccine. 2019. PMID: 30554797 Free article.
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults.
Loebermann M, Fritzsche C, Geerdes-Fenge H, Heijnen E, Kirby D, Reisinger EC. Loebermann M, et al. Infection. 2019 Feb;47(1):105-109. doi: 10.1007/s15010-018-1233-2. Epub 2018 Oct 8. Infection. 2019. PMID: 30298473 Clinical Trial.
84 results